Sinew Pharma (ROCO:6634) Buyback Yield %: 0.00 (As of Sep. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6634 Sinew Pharma Inc ROCO:6634
36 GF Score
Price NT$55.70
! 2 Warning Signs
View Full Analysis

What is Sinew Pharma Buyback Yield %?

Sinew Pharma ROCO:6634 -0.54% 36 Buyback Yield % is 0.00 as of Sep. 03, 2026. GuruFocus rates ROCO:6634 with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 699 Biotechnology companies, Sinew Pharma ranks worse than 143061.37% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Sinew Pharma's current buyback yield was 0.00%.

Sinew Pharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Sinew Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinew Pharma Buyback Yield % Chart

Sinew Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.43 -0.18 -0.37 -0.11 -0.02

Sinew Pharma Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.11 -0.02 -0.02 0.00

ROCO:6634 vs VRTX, REGN, MRNA: Buyback Yield % Comparison

For the Biotechnology subindustry, Sinew Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinew Pharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinew Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Sinew Pharma's Buyback Yield % falls into.


ROCO:6634
36GF Score
Sinew Pharma Inc ROCO:6634
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinew Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Sinew Pharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0.645) / 2790.96435
=-0.02%

Sinew Pharma's annualized Buyback Yield for the quarter that ended in Jun. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 5182.7103
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Sinew Pharma (ROCO:6634) has a Buyback Yield % of 0.00 as of Sep. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Sinew Pharma and its competitors. According to the industry distribution chart, Sinew Pharma ranks #999999 out of 699 companies in the Biotechnology industry.
Is Sinew Pharma's Buyback Yield % too high?
Sinew Pharma's current Buyback Yield % is 0.00. Based on the distribution chart, Sinew Pharma ranks #999999 out of 699 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sinew Pharma has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Sinew Pharma's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sinew Pharma ranks #999999 out of 699 companies for Buyback Yield %. This places Sinew Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Sinew Pharma and its competitors. Sinew Pharma's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinew Pharma stock overvalued right now?
Sinew Pharma (ROCO:6634) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Sinew Pharma's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Sinew Pharma (ROCO:6634), the current Buyback Yield % is 0.00 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sinew Pharma Business Description

Address Xueyin Road, Lane 130, Section 1, C516, Building C, Number 99, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.
36GF Score

Get the complete analysis for ROCO:6634

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$55.70
Price